[go: up one dir, main page]

NO20025567D0 - Rensing av en trippelhelixformasjon med et immobilisert oligonukleotid - Google Patents

Rensing av en trippelhelixformasjon med et immobilisert oligonukleotid

Info

Publication number
NO20025567D0
NO20025567D0 NO20025567A NO20025567A NO20025567D0 NO 20025567 D0 NO20025567 D0 NO 20025567D0 NO 20025567 A NO20025567 A NO 20025567A NO 20025567 A NO20025567 A NO 20025567A NO 20025567 D0 NO20025567 D0 NO 20025567D0
Authority
NO
Norway
Prior art keywords
purification
triple helix
helix formation
immobilized oligonucleotide
dna
Prior art date
Application number
NO20025567A
Other languages
English (en)
Other versions
NO330571B1 (no
NO20025567L (no
Inventor
Joel Crouzet
Daniel Scherman
Pierre Wils
Francis Blanche
Beatrice Cameron
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/580,923 external-priority patent/US6319672B1/en
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20025567D0 publication Critical patent/NO20025567D0/no
Publication of NO20025567L publication Critical patent/NO20025567L/no
Publication of NO330571B1 publication Critical patent/NO330571B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6839Triple helix formation or other higher order conformations in hybridisation assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20025567A 2000-05-26 2002-11-20 Fremgangsmate for a rense dobbelttradet DNA fra en losning NO330571B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/580,923 US6319672B1 (en) 1994-12-16 2000-05-26 Purification of a triple helix formation with an immobilized oligonucleotide
PCT/US2001/017122 WO2001092511A2 (en) 2000-05-26 2001-05-25 Purification of a triple heli formation with an immobilized oligonucleotide

Publications (3)

Publication Number Publication Date
NO20025567D0 true NO20025567D0 (no) 2002-11-20
NO20025567L NO20025567L (no) 2003-01-23
NO330571B1 NO330571B1 (no) 2011-05-16

Family

ID=24323138

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025567A NO330571B1 (no) 2000-05-26 2002-11-20 Fremgangsmate for a rense dobbelttradet DNA fra en losning

Country Status (22)

Country Link
EP (1) EP1290156B1 (no)
JP (1) JP4803945B2 (no)
KR (1) KR100853040B1 (no)
CN (1) CN1446258B (no)
AT (1) ATE382688T1 (no)
AU (3) AU6345901A (no)
BR (1) BR0111145B1 (no)
CA (1) CA2410263C (no)
CZ (1) CZ303086B6 (no)
DE (1) DE60132200T2 (no)
DK (1) DK1290156T3 (no)
ES (1) ES2298239T3 (no)
HU (1) HU228891B1 (no)
IL (2) IL152860A0 (no)
MX (1) MXPA02011463A (no)
NO (1) NO330571B1 (no)
NZ (1) NZ522860A (no)
PT (1) PT1290156E (no)
RU (1) RU2315104C2 (no)
SK (1) SK287662B6 (no)
WO (1) WO2001092511A2 (no)
ZA (1) ZA200209579B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101006170A (zh) * 2004-04-19 2007-07-25 森特利昂公司 纯化质粒dna的方法
SI1737945T1 (sl) * 2004-04-19 2011-05-31 Aventis Pharma Sa Postopek za čiščenje plazmidne DNA
WO2017186815A1 (en) * 2016-04-26 2017-11-02 Proqr Therapeutics Ii B.V. Antisense oligonucleotides for enhanced expression of frataxin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681940A (en) * 1994-11-02 1997-10-28 Icn Pharmaceuticals Sugar modified nucleosides and oligonucleotides
FR2728264B1 (fr) 1994-12-16 1997-01-31 Rhone Poulenc Rorer Sa Purification d'adn par formation de triple helice avec un oligonucleotide immobilise
FR2731014B1 (fr) * 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa Molecules d'adn, preparation et utilisation en therapie genique
FR2746412B1 (fr) * 1996-03-21 1998-06-12 Rhone Poulenc Rorer Sa Purification d'adn plasmidique de qualite pharmaceutique
CA2323831A1 (fr) * 1998-03-24 1999-09-30 Aventis Pharma S.A. Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations

Also Published As

Publication number Publication date
IL152860A0 (en) 2003-06-24
SK287662B6 (sk) 2011-05-06
SK16602002A3 (sk) 2003-06-03
WO2001092511A3 (en) 2002-04-11
EP1290156A2 (en) 2003-03-12
ES2298239T3 (es) 2008-05-16
CA2410263C (en) 2014-02-04
MXPA02011463A (es) 2004-09-06
HUP0302565A3 (en) 2010-01-28
RU2315104C2 (ru) 2008-01-20
CA2410263A1 (en) 2001-12-06
JP4803945B2 (ja) 2011-10-26
HU228891B1 (en) 2013-06-28
JP2003534799A (ja) 2003-11-25
CN1446258B (zh) 2013-01-09
DE60132200D1 (de) 2008-02-14
DE60132200T2 (de) 2008-12-18
PT1290156E (pt) 2008-02-21
BR0111145B1 (pt) 2013-06-04
AU2007202804B2 (en) 2011-04-07
NO330571B1 (no) 2011-05-16
BR0111145A (pt) 2003-04-15
AU2007202804B8 (en) 2011-07-14
PL359265A1 (en) 2004-08-23
ATE382688T1 (de) 2008-01-15
IL196444A (en) 2011-05-31
CZ20023865A3 (cs) 2003-04-16
WO2001092511A2 (en) 2001-12-06
AU6345901A (en) 2001-12-11
HUP0302565A2 (hu) 2003-10-28
DK1290156T3 (da) 2008-05-13
AU2001263459B2 (en) 2007-03-15
AU2007202804A1 (en) 2007-07-12
KR100853040B1 (ko) 2008-08-19
NZ522860A (en) 2004-09-24
CZ303086B6 (cs) 2012-03-28
ZA200209579B (en) 2003-10-15
NO20025567L (no) 2003-01-23
CN1446258A (zh) 2003-10-01
EP1290156B1 (en) 2008-01-02
KR20030027894A (ko) 2003-04-07

Similar Documents

Publication Publication Date Title
Xu et al. A novel 5'-iodonucleoside allows efficient nonenzymatic ligation of single-stranded and duplex DNAs
MX9703670A (es) Purificacion de adn mediante la formacion de triple helice con un oligonucleotido inmovilizado.
ATE346938T1 (de) Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen
WO2004094635A3 (en) Compositions and methods for using a solid support to purify rna
CY1112010T1 (el) Μια μεθοδος για την απομακρυνση της μολυνσης απο c, ν χρησιμοποιωντας ετεροτροφα βακτηρια οξειδωσης της αμμωνιας
DE60320780D1 (de) Funktionalisierte nanopartikel und verwendungsverfahren
ATE213664T1 (de) Formkörper und verfahren zu dessen herstellung
NZ515673A (en) Compositions and methods for labeling of nucleic acid molecules
WO2003048378A3 (en) Methods and compositions for selectively cleaving dna containing duplex acids in a complex nucleic acid mixture
DE50208601D1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
NO20025567D0 (no) Rensing av en trippelhelixformasjon med et immobilisert oligonukleotid
WO2012098171A3 (fr) Procédé de traitement biologique d'eaux usées par biomasse granulaire aérobie
WO2001023618A3 (en) Compositions and methods for reducing oligonucleotide hybridization and priming specificity
BR0004000A (pt) Processo para a preparação fermentativa de ácido d-pantotênico usando bactéria corineforme
DE60237382D1 (de) Verfahren zur gewinnung von indolocarbazolen mit hilfe von rebeccamycin-biosynthesegenen
Grau et al. Transcription of the Bacteriophage T4 Template: Strand Selection by E. coli RNA Polymerase in vitro
EP1281678A3 (en) Process for the treatment of biological sludge generated by the purification of wastewater
DE60111939D1 (de) Verfahren zur biologischen reinigung von abwasser
RU2002135091A (ru) Очистка трехспиральной структуры с помощью иммобилизованного олигонуклеотида
WO2001040510A3 (de) Dynamische sequenzierung durch hybridisierung
WO2022232134A1 (en) Compositions and methods for phosphoramedite-free enzymatic synthesis of nucleic acids
EA200300385A1 (ru) Способ образования комплекса
RU2002110024A (ru) Способ анаэробной микробиологической очистки воды от органических соединений с использованием азотной кислоты в качестве акцептора электронов

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: EHRNER & DELMAR PATENTBYRA AB, BOX

CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA

CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA

MM1K Lapsed by not paying the annual fees